An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.


  • Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
  • Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
  • William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'

Topics + Tags


comments powered by Disqus
Most Recent Shows

The State Of The Presidential Race

Monday, Oct 24 2016Early voting is underway in states across the country. Just over two weeks before the presidential election, a look at the latest polls, the electoral map and end-of-the-line strategies for both campaigns.

Friday News Roundup – International

Friday, Oct 21 2016The Islamic State launches a counterattack in the Iraqi city of Kirkuk, as the battle to retake Mosul intensifies. Ecuador cuts off Internet access to WikiLeaks founder Julian Assange. And the president of the Philippines says his country is pivoting away from the U.S. A panel of journalists joins guest host Derek McGinty for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, Oct 21 2016In the final debate, Donald Trump refuses to say whether he’ll accept the election results. North Carolina officials investigate the firebombing of Republican Party headquarters. And a police chiefs’ organization apologizes for ‘historical mistreatment of minorities.’ A panel of journalists joins guest host Derek McGinty for analysis of the week's top national news stories.